NINGBO INNO PHARMCHEM CO.,LTD. is a distinguished manufacturer and supplier of pharmaceutical intermediates, with 6-Chloro-3-Methyluracil (CAS 4318-56-3) being a prime example of our commitment to quality and innovation.

This white to off-white crystalline powder, a derivative of pyrimidine, is a fundamental component in the synthesis of various active pharmaceutical ingredients (APIs). Its unique chemical structure and properties, specifically denoted by its CAS number 4318-56-3, make it highly sought after in the chemical building blocks for antibacterials and other therapeutic agents.

The significance of 6-Chloro-3-Methyluracil in pharmaceutical intermediates manufacturing cannot be overstated. It serves as a critical alogliptin intermediate raw material, playing a direct role in the production of a medication vital for type 2 diabetes management. The consistent demand for such medications necessitates a reliable source of high-quality intermediates. Furthermore, its application in the synthesis of antibacterial agents positions it as a key player in the ongoing fight against microbial resistance.

Understanding the synthesis pathways of 3-methyl-6-chlorouracil is integral to ensuring product quality and efficiency. NINGBO INNO PHARMCHEM CO.,LTD. focuses on optimizing these processes to deliver a high purity pharmaceutical powder that meets stringent industry standards. This commitment to quality assurance is what sets us apart as a reliable supplier.

The CAS 4318-56-3 chemical properties are well-documented, providing researchers and manufacturers with the essential data for integration into their complex synthesis protocols. Whether for initial research and development or for large-scale commercial production, the reliability of this intermediate is paramount.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting the pharmaceutical industry by providing top-tier 6-chloro-3-methyluracil pharmaceutical intermediates. Our expertise in chemical synthesis and our stringent quality control measures ensure that our clients receive products that contribute to the development of safe and effective medicines.